The report looks at the complex, ever-changing antiretroviral and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work in over 30 countries.
We are deeply saddened to announce the passing of our longtime colleague, Ed Wood.
Cancer Access Partnership is expected to result in a 59 percent savings on procured cancer medicines.
Agreement with Omega Diagnostics will help deliver same-day CD4 testing for people living with HIV in over 130 low- and middle-income countries at just US$3.98 per test.
Preclinical work in mice and primates has demonstrated that a single injection of a new drug developed by UNMC is effective in achieving blood drug levels known to be active against HIV for up to one year.
The new site is designed to better connect partners, staff, and the public with the organization’s work in low- and middle-income countries.
Ira C. Magaziner will continue to work with CHAI as a senior advisor and help drive new CHAI initiatives.
The theme for the 2018 Annual Report is ‘Our Approach in Action’. There are examples in each program section of a time that CHAI’s approach was successfully applied to support our partners toward our mission.
Allied Against Cancer will work to improve access to high-quality cancer treatment ARMONK, NY, Nov. 11, 2019 — IBM (NYSE: IBM), American Cancer Society (ACS), the National Comprehensive Cancer Network® (NCCN®) and the Clinton Health Access Initiative (CHAI), today...
ABUJA, NIGERIA, Oct. 29, 2019 — Nigeria’s Federal Ministry of Health today announced an innovative partnership to deliver lifesaving chemotherapies for cancer treatment to seven teaching hospitals throughout the country. As a result of the partnership, Nigerians are...
